English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Talk

Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy

MPS-Authors
/persons/resource/persons227037

Gränicher,  Gwendal
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons265590

Göbel,  Sven
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons201848

Marichal-Gallardo,  Pavel
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons86303

Genzel,  Yvonne
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons86448

Reichl,  Udo
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;
Otto-von-Guericke-Universität Magdeburg, External Organizations;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Gränicher, G., Göbel, S., Marichal-Gallardo, P., Jordan, I., Sandig, V., Genzel, Y., et al. (2022). Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy. Talk presented at 27th ESACT Meeting. Lisbon (Portugal). 2022-06-26 - 2022-06-29.


Cite as: https://hdl.handle.net/21.11116/0000-000A-CB1D-2
Abstract
There is no abstract available